The mechanism of inhibition of factor III (thromboplastin) activity by apolipoprotein B-100 - Protein-protein interactions

被引:21
作者
Ettelaie, C
James, NJ
Wilbourn, B
Adam, JM
Naseem, KM
Bruckdorfer, KR
机构
[1] Department of Biochemistry, Royal Free Hospital, School of Medicine, London
[2] Department of Biochemistry, Royal Free Hospital, School of Medicine, London NW3 2PF, Rowland Hill St.
基金
英国惠康基金;
关键词
apolipoprotein B-100; factor III (thromboplastin); factor VII; factor X; UV spectroscopy;
D O I
10.1161/01.ATV.16.5.639
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Factor III (thromboplastin) activity is inhibited by apoB-100, but the mechanism of inhibition is unknown. By examining the effect of purified apoB-100 on factor III activity, we showed that apoB-100 can inhibit factor III via a different mechanism from that caused by the tissue-factor pathway-inhibitor, which is mainly carried on the surface of lipoproteins. Although the presence of calcium ions and factors X and VII may enhance the rate of inhibition, they are not a prerequisite for the inhibition of factor III by apoB-100. In addition, by investigating the changes in the UV spectra of apoB-100 on interaction with factor III and factors X and VII and by assigning the shifts in absorption spectra to particular amino acids, we showed that these interactions involve negative and positive residues within these proteins. By following the rates of interactions between apoB-100 and either factors III, X, or VII, a two-step mechanism for the inhibition process involving factors X and VII was postulated. In this mechanism, the primary interaction of apoB-100 with factor III is followed by a rate-limiting step that can be accelerated by the presence of either factor X or VII and leads to the inhibition of factor III. Furthermore, a computer-based analysis of the sequences of factor III revealed a possible binding site for apoB-100.
引用
收藏
页码:639 / 647
页数:9
相关论文
共 27 条
[1]  
[Anonymous], 1967, ULTRAVIOLET VISIBLE
[2]   OXIDIZED LOW-DENSITY-LIPOPROTEIN REDUCES PLASMA COAGULATION INVITRO [J].
AVIRAM, M ;
PRESSER, D .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1991, 51 (01) :17-21
[3]  
BAJAJ SP, 1976, J BIOL CHEM, V251, P5233
[4]  
BROZE GJ, 1987, BLOOD, V69, P150
[5]  
BRUCKDORFER KR, 1995, BIOCHEM SOC T, V23, P243
[6]  
CARSON SD, 1987, J BIOL CHEM, V262, P718
[7]   EMPIRICAL PREDICTIONS OF PROTEIN CONFORMATION [J].
CHOU, PY ;
FASMAN, GD .
ANNUAL REVIEW OF BIOCHEMISTRY, 1978, 47 :251-276
[8]  
DELOOF H, 1987, J LIPID RES, V28, P1455
[9]   CONFORMATIONAL CHANGE IN PANCREATIC LIPASE INDUCED BY COLIPASE [J].
ERLANSONALBERTSSON, C ;
AKERLUND, HE .
FEBS LETTERS, 1982, 144 (01) :38-42
[10]   THE EFFECT OF LIPID-PEROXIDATION AND LIPOLYSIS ON THE ABILITY OF LIPOPROTEINS TO INFLUENCE THROMBOPLASTIN ACTIVITY [J].
ETTELAIE, C ;
HOWELL, RM ;
BRUCKDORFER, KR .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1995, 1257 (01) :25-30